At the annual conference of the American Society of Clinical Oncology, an American oncologist will present a study according to which patients with cancer and taking antidiabetic drugs such as Ozempic or Wegovy are less likely to develop their disease.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
At the annual conference of the American Society of Clinical Oncology, an American oncologist will present a study according to which patients with cancer and taking antidiabetic drugs such as Ozempic or Wegovy are less likely to develop their disease.